NCT05478330View on ClinicalTrials.gov

Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Interventions
DRUG

Flutamide 1% gel

Group A: Flutamide-treated patients: Consisted of 25 patients with acne vulgaris treated with 1% Flutamide topical gel on the face two times per day for a duration of 8 weeks.

DRUG

topical gel without flutamide

Group B: Consisted of 25 patients with acne vulgaris treated with topical gel with the same component as the other group, except for flutamide, on the face twice per day for a duration of 8 weeks.

Trial Locations (1)

2543

Reham Essam, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05478330 - Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter